Chemoinformaics analysis of (3R)-3-[(1S,4R)-4-METHYL-1-(2-METHYLPROPANOYL)-3-OXOCYCLOHEXYL]BUTANOIC ACID
| Molecular Weight | 268.353 | nRot | 5 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 9 |
| Exact Molecular Weight | 268.167 | nRing | 1 |
| Solubility: LogS | -1.794 | nHRing | 0 |
| Solubility: LogP | 1.72 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 44.261 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.832 |
| Synth | 4.12 |
| Natural Product Likeliness | 1.448 |
| NR-PPAR-gamma | 0.64 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -5.04 |
| MDCK | 0.0000296 |
| BBB | 0.079 |
| PPB | 0.878408 |
| VDSS | 0.183 |
| FU | 0.157402 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.417 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.888 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.944 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.256 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.172 |
| CL | 14.868 |
| T12 | 0.89 |
| hERG | 0.002 |
| Ames | 0.021 |
| ROA | 0.293 |
| SkinSen | 0.039 |
| Carcinogencity | 0.033 |
| EI | 0.069 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.918752 |